Search for: "IN RE WYETH"
Results 1 - 20
of 702
Sort by Relevance
|
Sort by Date
12 Mar 2024, 12:46 pm
Wyeth-Ayerst Laboratories Co., 278 F.Supp.2d 684, 700 (W.D.N.C. 2003) (expert witnesses may not opine about corporate intent and motive) (barring Dr. [read post]
28 Nov 2023, 5:24 am
United Technologies Corp., 487 U.S. 500 (1988) Wyeth v. [read post]
25 Aug 2023, 6:22 pm
Wyeth-Ayerst Labs., No. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
4 Nov 2022, 9:13 am
The manufacturer of the drug -- Wyeth -- had previously gotten into tons of trouble with the FDA for false advertising for pushing doctors to use amiodarone in situations far beyond the whole "last resort" purpose for which it was approved. [read post]
4 Oct 2022, 7:00 am
Wyeth,131 S. [read post]
1 Jun 2022, 10:23 am
“Most of the interview was talking about the impact of this Supreme Court decision, Wyeth v. [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
17 Oct 2021, 2:17 pm
INTRODUCTION The new, third edition of the Reference Manual on Scientific Evidence was released to the public in September 2011, as a joint production of the National Academies of Science, and the Federal Judicial Center. [read post]
29 Mar 2021, 7:10 pm
In one Fen-Phen case, one plaintiff sought to retain an expert witness previously retained by Wyeth to testify about the same diet drug (fenfluramine) in a case brought by a different plaintiff. [read post]
25 Jan 2021, 9:39 am
Martinotti in the In re Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation. [read post]
23 Dec 2020, 5:31 am
The AmeriKat has her mittens onin time for the cold, wintertradition of the AIPPI patentroundupA couple of weeks ago, instead of descending upon the hospitality of Hogan Lovells' London offices to devour patent law and mince pies, AIPPI UK members instead virtually attended the annual tradition that is the AIPPI UK Patent Cases Roundup. [read post]
15 Nov 2020, 6:44 am
The court issued an important short-opinion, In re Ivantis, Inc. [read post]
12 Nov 2020, 5:55 am
“The corporations we’re suing knew full well the potential harms they were inflicting on our environment, but chose to forge ahead anyway. [read post]
28 May 2020, 5:29 am
Despite the confusing verbiage, these judicial rulings are a serious deviation from the text of Rule 702, as well as the Advisory Committee Note to the 2000 Amendments, which embraced the standard articulated in In re Paoli, that “any step that renders the analysis unreliable . . . renders the expert’s testimony inadmissible. [read post]
13 May 2020, 2:03 am
Wyeth, 738 F. [read post]
27 Nov 2019, 3:33 am
See also BloombergLaw post: Merck Gets Second Shot at Axing Wyeth’s Vaccine Patent Claim [read post]
5 Nov 2019, 3:36 am
by Dennis Crouch In ChargePoint, the Federal Circuit discussed the 19th Century patent case of Wyeth v. [read post]
23 May 2019, 9:30 pm
Supreme Court ruled that judges rather than juries should determine whether or not pharmaceutical product liability claims may proceed under the “clear evidence” standard established in Wyeth v. [read post]
